{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilmington",
      "state": "DE",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89606",
      "recalling_firm": "Positive Health",
      "address_1": "1013 Centre Rd",
      "address_2": "Suite 403B",
      "postal_code": "19805-1265",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Product was distributed nationwide via the internet through Amazon Marketplace.",
      "recall_number": "D-0645-2022",
      "product_description": "RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08JCWG84D, barcode X002NI8PE1.",
      "product_quantity": "5,500 cartons",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",
      "recall_initiation_date": "20220210",
      "center_classification_date": "20220304",
      "termination_date": "20220603",
      "report_date": "20220302",
      "code_info": "Lot # 48658908, Exp. date 09/09/2023",
      "more_code_info": ""
    }
  ]
}